CPC Outpatient Unit

The CPCs aims to establish clinically and molecularly phenotyped patient cohorts that are assessed using conventional parameters and innovative biomarkers. The results out of those studies will contribute to a better patient care.

The partners within the CPC jointly operate an outpatient unit dedicated to coordinate studies involving lung disease patients. Essential part in those studies is the clinical and molecular phenotyping of patient cohorts with different lung diseases (such as COPD, Asthma, interstitial lung disease, BPD, lung transplantation, cystic fibrosis, lung cancer). Investigations include special criteria of the clinical development of a disease, expression of biomarkers, response to therapies, or complications. The clinical and molecular phenotyping will be performed in the specialized clinics at the Munich University Hospital or the Asklepios Fachkliniken. The clinicians are collection patient biomaterials that will be analysed in the research units at the CPC and the Institute of Lung biology and disease